About this trial
Benzodiazepines or related drug (BZDR) are consumed for hypnotic or anxiolytic purposes in most cases. The consequences of BZDR are multiple with an increased risk of daytime sedation, balance disorders leading to falls and fractures, cognitive disorders, road accidents and dementia. Given their comorbidities, physiological changes, and multiple medications, the elderly are more at risk of suffering from BZDR adverse events.
Interprofessional collaboration has shown efficacy in improving prescribing appropriateness and may affect patients outcomes positively. Morever, motivational interviews (MI) may reduce the extent of substance abuse compared to no intervention.
Eligibility criteria
Qualifiers
outpatients aged 65 and over
followed by the general practitioner and the pharmacist of the GP-PO pair
having a prescription for an anxiolytic or hypnotic BZDR prescribed at least 4 times in the past year
the last prescription being less than 3 months old
Disqualifiers
patients living in an institution
participating in a clinical trial
with epilepsy
active depression
Trial design
Treatments tested in this trial
- GP - pharmacist collaboration and pharmacist motivational interviewing
Treatment groups
Sponsors and collaborators
Nantes University Hospital
Lead sponsor
Université de Nantes
Collaborator